NASDAQ:OFIX

Orthofix International N.v Stock News

etoro logo Buy OFIX
*Your capital is at risk
$9.72
+0.0100 (+0.103%)
At Close: Jun 03, 2026
25.74% price returns over the past month with earnings surprise of $45.3 million on Q2 results. 18.31% CAGR growth in FCF with additional 18% reinvestment in net working capital bolsters consensus FCF
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
GenMark Diagnostics (NASDAQ:GNMK) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of th
Orthofix (OFIX) delivered earnings and revenue surprises of 26.25% and 35.94%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Net sales of $73.1 million, a decrease of 37% compared to prior year on a reported and constant currency basis Record Motion Preservation sales quarter of $3.6 million in the U.S., an increase of 24%

Orthofix Reports Second Quarter 2020 Results

11:00am, Thursday, 06'th Aug 2020
Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the second quarter ended June 30, 2020. Net sales were $73.1 million, earnings per share ("EPS") was ($0.96) and adjusted E
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) ABIOMED, Inc. (NASDAQ: ABMD) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
Orthofix Medical Inc. (NASDAQ:OFIX) today announced that President and Chief Executive Officer Jon Serbousek will present at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13,
Orthofix Medical Inc. (NASDAQ:OFIX) today announced that President and Chief Executive Officer Jon Serbousek will present at the Canaccord Genuity 40t
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...
Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the second quarte
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans
Orthofix (OFIX) rides high on dual regulatory clearances for its deformity correction system, thus solidifying its pediatric orthopedics portfolio.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE